111, Inc. (ADR)
General ticker "YI" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $45.7M (TTM average)
111, Inc. (ADR) does not follow the US Stock Market performance with the rate: -19.7%.
Estimated limits based on current volatility of 2.3%: low 3.09$, high 3.24$
Factors to consider:
- Total employees count: 144 (0.0%) as of 2025
- Current price 33.5% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.17$, 11.21$]
- 2025-12-31 to 2026-12-31 estimated range: [4.71$, 11.98$]
Financial Metrics affecting the YI estimates:
- Positive: with PPE of -10.2 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 56.82 > 24.19
- Positive: -13.52 < Operating profit margin, % of 0.01
- Negative: Shareholder equity ratio, % of -23.05 <= 7.04
- Negative: Industry earnings per price (median), % of -1.72 <= 0
- Positive: Inventory ratio change, % of 0.12 <= 0.41
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -0.97
- Positive: Interest expense per share per price, % of 6.12 <= 10.35
Short-term YI quotes
Long-term YI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY13,516.70MM | CNY14,948.13MM | CNY14,401.25MM |
| Operating Expenses | CNY13,887.70MM | CNY15,298.23MM | CNY14,399.14MM |
| Operating Income | CNY-371.00MM | CNY-350.10MM | CNY2.11MM |
| Non-Operating Income | CNY-5.07MM | CNY-3.08MM | CNY-22.79MM |
| Interest Expense | CNY13.44MM | CNY20.14MM | CNY28.33MM |
| Income(Loss) | CNY-376.07MM | CNY-353.18MM | CNY-20.68MM |
| Taxes | CNY-0.00MM | CNY-0.25MM | CNY-0.10MM |
| Net Income(Loss)* | CNY-416.88MM | CNY-392.69MM | CNY-64.74MM |
| Stockholders Equity | CNY-414.60MM | CNY-583.45MM | CNY-642.64MM |
| Inventory | CNY1,498.90MM | CNY1,419.40MM | CNY1,387.40MM |
| Assets | CNY3,473.81MM | CNY3,089.04MM | CNY2,787.75MM |
| Operating Cash Flow | CNY-23.15MM | CNY-447.24MM | CNY263.02MM |
| Capital expenditure | CNY31.57MM | CNY9.82MM | CNY15.20MM |
| Investing Cash Flow | CNY-47.17MM | CNY151.74MM | CNY37.38MM |
| Financing Cash Flow | CNY22.73MM | CNY205.98MM | CNY-406.24MM |
| Earnings Per Share** | CNY-50.04 | CNY-46.58 | CNY-7.51 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.